Catyalyst Pharma (CPRX) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.39 +0.03%
Revenue Growth %: +5.9%
Financial Fact:
General and administrative: 1.42M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +5.9%
Financial Fact:
General and administrative: 1.42M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Catyalyst Pharma (NASDAQ: CPRX) reported Q4 EPS of ($0.06), in-line with the analyst estimate of ($0.06).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Carnival shares drop despite earnings beat on weak guidance
- Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
